Lpl Financial LLC Ascendis Pharma A/S Transaction History

Lpl Financial LLC

$238 Billion
Q4 2024

A detailed history of Lpl Financial LLC transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Lpl Financial LLC holds 4,199 shares of ASND stock, worth $634,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,199

Previous 2,622 60.14%

Holding current value

$634,300

Previous $391,000 47.83%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$122.0 - $146.6 $192,394 - $231,188	1,577 Added 60.14%	4,199 $578,000
Q3 2024 Nov 08, 2024	SELL	$113.0 - $153.43 $28,476 - $38,664	-252 Reduced 8.77%	2,622 $391,000
Q2 2024 Aug 07, 2024	BUY	$121.07 - $153.67 $35,836 - $45,486	296 Added 11.48%	2,874 $391,000
Q1 2024 May 10, 2024	SELL	$123.45 - $159.4 $34,072 - $43,994	-276 Reduced 9.67%	2,578 $389,000
Q4 2023 Feb 14, 2024	SELL	$86.1 - $127.36 $32,890 - $48,651	-382 Reduced 11.8%	2,854 $359,000
Q3 2023 Nov 13, 2023	SELL	$86.5 - $103.97 $51,640 - $62,070	-597 Reduced 15.58%	3,236 $303,000
Q2 2023 Jul 31, 2023	BUY	$69.96 - $97.84 $268,156 - $375,020	3,833 New	3,833 $342,000
Q4 2022 Feb 07, 2023	BUY	$99.42 - $131.97 $172,593 - $229,099	1,736 New	1,736 $212,000
Q2 2022 Aug 12, 2022	SELL	$78.08 - $117.61 $4,294 - $6,468	-55 Reduced 2.35%	2,288 $213,000
Q1 2022 May 16, 2022	SELL	$102.18 - $135.75 $40,156 - $53,349	-393 Reduced 14.36%	2,343 $275,000
Q4 2021 Feb 14, 2022	BUY	$127.1 - $169.66 $70,540 - $94,161	555 Added 25.45%	2,736 $368,000
Q3 2021 Nov 15, 2021	SELL	$112.67 - $176.92 $13,182 - $20,699	-117 Reduced 5.09%	2,181 $348,000
Q2 2021 Aug 13, 2021	BUY	$121.62 - $145.29 $3,040 - $3,632	25 Added 1.1%	2,298 $302,000
Q1 2021 May 14, 2021	SELL	$124.92 - $173.33 $6,246 - $8,666	-50 Reduced 2.15%	2,273 $293,000
Q4 2020 Feb 12, 2021	SELL	$151.2 - $182.76 $31,147 - $37,648	-206 Reduced 8.15%	2,323 $387,000
Q3 2020 Nov 09, 2020	BUY	$134.29 - $154.32 $2,820 - $3,240	21 Added 0.84%	2,529 $390,000
Q2 2020 Aug 13, 2020	SELL	$110.87 - $156.01 $1,108 - $1,560	-10 Reduced 0.4%	2,508 $371,000
Q1 2020 May 14, 2020	BUY	$97.01 - $145.11 $244,271 - $365,386	2,518 New	2,518 $284,000
Q3 2019 Nov 13, 2019	SELL	$95.8 - $118.9 $213,921 - $265,503	-2,233 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$107.11 - $132.09 $14,031 - $17,303	131 Added 6.23%	2,233 $257,000
Q1 2019 May 08, 2019	BUY	$62.15 - $129.99 $130,639 - $273,238	2,102 New	2,102 $247,000

Others Institutions Holding ASND

# of Institutions

236

Shares Held

60.2M

Call Options Held

80.3K

Put Options Held

216K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $8.43B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Ascendis Pharma A/S Transaction History